HCG 6 — Class I drug recall D-0648-2022
Terminated recall by Revive Rx LLC dba Revive Rx Pharmacy, reported 2022-02-23, distributed nationwide. Non-sterility; bacterial contamination identified as Paenibacillus lautus.
| Recall number | D-0648-2022 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Revive Rx LLC dba Revive Rx Pharmacy, Houston, TX, United States |
| Recall initiated | 2022-02-11 |
| Classified | 2022-03-08 |
| Reported by FDA | 2022-02-23 |
| Terminated | 2024-08-23 |
| Distributed | Nationwide (US) |
| Quantity | 115 vials |
| Reason classes | microbial contamination, sterility |
| NDC | 88888-1739-01 |
| Lot numbers | 631359 |
| Expiration dates | 2022-05-01 |
Product
HCG 6,000iu (lyo) Human Chorionic Gonadotropin Inj., For Sub-Q or IM Use Only, Not For IV Use, Vial, Rx Only, Compounded By: Revive Rx 3831 Golf Dr., Houston, TX 77018, NDC: 88888-1739-01.
Reason for recall
Non-sterility; bacterial contamination identified as Paenibacillus lautus.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0648-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.